No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen
British Study Shows Vaccines Weaken Against Omicron, but Boosters Help
Third dose of the vaccine appears to boost level of protection from about 35 percent to about 75 percent
U.S. COVID-19 Death Toll Passes 800,000
Rise from 700,000 to 800,000 happened in just 74 days compared with 119 days for the previous 100,000 increase in deaths
Barrett Esophagus, Esophageal Cancer Diagnoses Down During Pandemic
Endoscopic ablation therapy also down early in the pandemic, but not esophagectomy
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 6 to 10, 2021. This …
Half of U.S. Parents of Teens Got Their Child Vaccinated, but Uptake Slows
Nationwide telephone and online survey of nearly 1,200 parents with a child younger than 18 years was conducted Nov. 8 to 23
Rates of COVID-19, Severe Illness Lower With BNT162b2 Booster Dose
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
Effectiveness of mRNA COVID-19 Vaccines Lower at ≥120 Days
Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
Pfizer first sought the approval for using the boosters in this age group at the end of November
200 Million Americans Are Now Fully Vaccinated as COVID-19 Cases Spike
White House officials noted that 12.5 million shots were given last week, the highest weekly total since May